[S,S]-Reboxetine add-on trial: a randomized, double-blind, placebo-controlled, multi-center trial of [S,S]-reboxetine in patients with postherpetic neuralgia (PHN) concomitantly treated with pregabalin
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2016
At a glance
- Drugs Esreboxetine; Pregabalin
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Pfizer
- 15 Jul 2008 Status changed from recruiting to discontinued, due to insufficient clinical response, according to clinicaltrials.gov record.
- 01 Feb 2007 New trial locations added
- 15 Oct 2006 New trial record.